FDA issues warning letter to Intas’ plant in north India; okays Axsome’s drug for Alzheimer’s-related agitation
In Phispers this week, India’s Intas Pharmaceuticals received a warning letter from the US Food and Drug Administration (...
Impressions : 2066
Pfizer halts manufacturing post FDA inspection in India; Aurobindo buys Apotex’s European operations in 5 countries
This week, Phispers brings you news on US FDA’s new task force that will look for solutions to perpetual drug shortages. ...
Impressions : 5022
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.